Ledger.Open graph →
SEC Form D · Amendment · filed February 27, 2019

NEUROONE MEDICAL TECHNOLOGIES Corp

Offering
$10.0M
Sold
$993K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Minnetonka, MN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Jeffrey S. Mathiesen · Minnetonka, MNDirectorThomas A. Bachinski · Lakeville, MNExecDavid A. Rosa · Minnetonka, MNExec · DirectorPaul A. Buckman · Minnetonka, MNDirectorMark A. Christianson · Minnetonka, MNExecSuraj A. Kalia · Minnetonka, MNDirectorWestbrook Weaver · San Diego, CADirectorAlex Bashan · New York, NYDirectorJ. B. Ryan · Houston, TXExecAnusha P. Iyer · VIENNA, VADirectorDavid N. Ambrose · MONROVIA, CAExec · DirectorWalter Gilbert · Cambridge, MAExecThomas Powell · Reno, NVExecJan Hammer · MENLO PARK, CAExec · DirectorBaiju Bhatt · MENLO PARK, CADirectorDaniel Gallagher · MENLO PARK, CAExecJason Warnick · MENLO PARK, CADirectorJohn Decooman · TORONTO, Ontario, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗